KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Crescent Capital BDC (CCAP) Cash & Equivalents (2021 - 2025)

Historic Cash & Equivalents for Crescent Capital BDC (CCAP) over the last 5 years, with Q3 2025 value amounting to $5.8 million.

  • Crescent Capital BDC's Cash & Equivalents fell 6613.6% to $5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.8 million, marking a year-over-year decrease of 6613.6%. This contributed to the annual value of $10.1 million for FY2024, which is 3020.57% up from last year.
  • Crescent Capital BDC's Cash & Equivalents amounted to $5.8 million in Q3 2025, which was down 6613.6% from $9.7 million recorded in Q2 2025.
  • In the past 5 years, Crescent Capital BDC's Cash & Equivalents ranged from a high of $21.4 million in Q1 2023 and a low of $5.8 million during Q3 2025
  • In the last 5 years, Crescent Capital BDC's Cash & Equivalents had a median value of $9.7 million in 2025 and averaged $10.4 million.
  • As far as peak fluctuations go, Crescent Capital BDC's Cash & Equivalents skyrocketed by 9786.61% in 2022, and later crashed by 6855.97% in 2024.
  • Quarter analysis of 5 years shows Crescent Capital BDC's Cash & Equivalents stood at $10.1 million in 2021, then dropped by 19.02% to $8.2 million in 2022, then fell by 4.59% to $7.8 million in 2023, then surged by 30.21% to $10.1 million in 2024, then crashed by 42.88% to $5.8 million in 2025.
  • Its last three reported values are $5.8 million in Q3 2025, $9.7 million for Q2 2025, and $12.0 million during Q1 2025.